Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06DBJ
|
|||
| Former ID |
DIB013243
|
|||
| Drug Name |
REGN-846
|
|||
| Synonyms |
RENG-846; SAR-302352; SAR-302532
Click to Show/Hide
|
|||
| Indication | Atopic dermatitis [ICD-11: EA80; ICD-10: L20; ICD-9: 691.8, 692.9] | Phase 1/2 | [1] | |
| Company |
Regeneron pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01605708) Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.